Drug General Information (ID: DDIF1Z4BYJ)
Drug Name			Methohexital		Drug Info		Isocarboxazid		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Anesthetics				Antidepressants
Structure

Mechanism of Methohexital-Isocarboxazid Interaction (Severity Level: Major)
Increased risk of other adverse reactions (Unspecific) Click to Show/Hide Mechanism Graph
Drug Name		Methohexital				Isocarboxazid
Mechanism		General anesthetic				Increase the risk of hypotension or hypertension in combination with general anesthetics
Key Mechanism Factor 1
		Factor Name		Adverse reactions
		Factor Description		An adverse reaction is an unexpected negative reaction to a medication or treatment that happens even when it's used correctly.
Mechanism Description		Increased risk of adverse reactions by the combination of Methohexital and Isocarboxazid

Recommended Action
Management		The makers of MAOIs, both selective and nonselective, consider general anesthesia to be contraindicated in patients treated with MAOIs and recommend discontinuing MAOI therapy 10 to 14 days before elective surgery.

References
1	Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
2	Product Information. Marplan (isocarboxazid) Roche Laboratories, Nutley, NJ.
3	Product Information. Nardil (phenelzine). Parke-Dvis, Morris Plains, NJ.